Cargando…

Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD

BACKGROUND: Macrophages have been implicated in the pathogenesis of COPD. M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties. We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD. Our aim was to study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunz, Lisette IZ, Lapperre, Thérèse S, Snoeck-Stroband, Jiska B, Budulac, Simona E, Timens, Wim, van Wijngaarden, Simone, Schrumpf, Jasmijn A, Rabe, Klaus F, Postma, Dirkje S, Sterk, Peter J, Hiemstra, Pieter S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072953/
https://www.ncbi.nlm.nih.gov/pubmed/21426578
http://dx.doi.org/10.1186/1465-9921-12-34
_version_ 1782201596912861184
author Kunz, Lisette IZ
Lapperre, Thérèse S
Snoeck-Stroband, Jiska B
Budulac, Simona E
Timens, Wim
van Wijngaarden, Simone
Schrumpf, Jasmijn A
Rabe, Klaus F
Postma, Dirkje S
Sterk, Peter J
Hiemstra, Pieter S
author_facet Kunz, Lisette IZ
Lapperre, Thérèse S
Snoeck-Stroband, Jiska B
Budulac, Simona E
Timens, Wim
van Wijngaarden, Simone
Schrumpf, Jasmijn A
Rabe, Klaus F
Postma, Dirkje S
Sterk, Peter J
Hiemstra, Pieter S
author_sort Kunz, Lisette IZ
collection PubMed
description BACKGROUND: Macrophages have been implicated in the pathogenesis of COPD. M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties. We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD. Our aim was to study macrophage heterogeneity using the M2-marker CD163 and selected pro- and anti-inflammatory mediators in bronchoalveolar lavage (BAL) fluid and induced sputum from current smokers and ex-smokers with COPD. METHODS: 114 COPD patients (72 current smokers; 42 ex-smokers, median smoking cessation 3.5 years) were studied cross-sectionally and underwent sputum induction (M/F 99/15, age 62 ± 8 [mean ± SD] years, 42 (31-55) [median (range)] packyears, post-bronchodilator FEV(1 )63 ± 9% predicted, no steroids past 6 months). BAL was collected from 71 patients. CD163(+ )macrophages were quantified in BAL and sputum cytospins. Pro- and anti-inflammatory mediators were measured in BAL and sputum supernatants. RESULTS: Ex-smokers with COPD had a higher percentage, but lower number of CD163(+ )macrophages in BAL than current smokers (83.5% and 68.0%, p = 0.04; 5.6 and 20.1 ×10(4)/ml, p = 0.001 respectively). The percentage CD163(+ )M2 macrophages was higher in BAL compared to sputum (74.0% and 30.3%, p < 0.001). BAL M-CSF levels were higher in smokers than ex-smokers (571 pg/ml and 150 pg/ml, p = 0.001) and correlated with the number of CD163(+ )BAL macrophages (Rs = 0.38, p = 0.003). No significant differences were found between smokers and ex-smokers in the levels of pro-inflammatory (IL-6 and IL-8), and anti-inflammatory (elafin, and Secretory Leukocyte Protease Inhibitor [SLPI]) mediators in BAL and sputum. CONCLUSIONS: Our data suggest that smoking cessation partially changes the macrophage polarization in vivo in the periphery of the lung towards an anti-inflammatory phenotype, which is not accompanied by a decrease in inflammatory parameters.
format Text
id pubmed-3072953
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30729532011-04-09 Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD Kunz, Lisette IZ Lapperre, Thérèse S Snoeck-Stroband, Jiska B Budulac, Simona E Timens, Wim van Wijngaarden, Simone Schrumpf, Jasmijn A Rabe, Klaus F Postma, Dirkje S Sterk, Peter J Hiemstra, Pieter S Respir Res Research BACKGROUND: Macrophages have been implicated in the pathogenesis of COPD. M1 and M2 macrophages constitute subpopulations displaying pro- and anti-inflammatory properties. We hypothesized that smoking cessation affects macrophage heterogeneity in the lung of patients with COPD. Our aim was to study macrophage heterogeneity using the M2-marker CD163 and selected pro- and anti-inflammatory mediators in bronchoalveolar lavage (BAL) fluid and induced sputum from current smokers and ex-smokers with COPD. METHODS: 114 COPD patients (72 current smokers; 42 ex-smokers, median smoking cessation 3.5 years) were studied cross-sectionally and underwent sputum induction (M/F 99/15, age 62 ± 8 [mean ± SD] years, 42 (31-55) [median (range)] packyears, post-bronchodilator FEV(1 )63 ± 9% predicted, no steroids past 6 months). BAL was collected from 71 patients. CD163(+ )macrophages were quantified in BAL and sputum cytospins. Pro- and anti-inflammatory mediators were measured in BAL and sputum supernatants. RESULTS: Ex-smokers with COPD had a higher percentage, but lower number of CD163(+ )macrophages in BAL than current smokers (83.5% and 68.0%, p = 0.04; 5.6 and 20.1 ×10(4)/ml, p = 0.001 respectively). The percentage CD163(+ )M2 macrophages was higher in BAL compared to sputum (74.0% and 30.3%, p < 0.001). BAL M-CSF levels were higher in smokers than ex-smokers (571 pg/ml and 150 pg/ml, p = 0.001) and correlated with the number of CD163(+ )BAL macrophages (Rs = 0.38, p = 0.003). No significant differences were found between smokers and ex-smokers in the levels of pro-inflammatory (IL-6 and IL-8), and anti-inflammatory (elafin, and Secretory Leukocyte Protease Inhibitor [SLPI]) mediators in BAL and sputum. CONCLUSIONS: Our data suggest that smoking cessation partially changes the macrophage polarization in vivo in the periphery of the lung towards an anti-inflammatory phenotype, which is not accompanied by a decrease in inflammatory parameters. BioMed Central 2011 2011-03-22 /pmc/articles/PMC3072953/ /pubmed/21426578 http://dx.doi.org/10.1186/1465-9921-12-34 Text en Copyright ©2011 Kunz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kunz, Lisette IZ
Lapperre, Thérèse S
Snoeck-Stroband, Jiska B
Budulac, Simona E
Timens, Wim
van Wijngaarden, Simone
Schrumpf, Jasmijn A
Rabe, Klaus F
Postma, Dirkje S
Sterk, Peter J
Hiemstra, Pieter S
Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
title Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
title_full Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
title_fullStr Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
title_full_unstemmed Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
title_short Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
title_sort smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in copd
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072953/
https://www.ncbi.nlm.nih.gov/pubmed/21426578
http://dx.doi.org/10.1186/1465-9921-12-34
work_keys_str_mv AT kunzlisetteiz smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT lapperrethereses smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT snoeckstrobandjiskab smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT budulacsimonae smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT timenswim smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT vanwijngaardensimone smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT schrumpfjasmijna smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT rabeklausf smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT postmadirkjes smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT sterkpeterj smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT hiemstrapieters smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd
AT smokingstatusandantiinflammatorymacrophagesinbronchoalveolarlavageandinducedsputumincopd